DENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $961.48 Million

Wall Street analysts predict that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will report $961.48 million in sales for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have issued estimates for DENTSPLY SIRONA’s earnings, with the highest sales estimate coming in at $974.91 million and the lowest estimate coming in at $930.70 million. DENTSPLY SIRONA reported sales of $900.50 million in the same quarter last year, which indicates a positive year-over-year growth rate of 6.8%. The business is expected to report its next quarterly earnings report on Tuesday, May 8th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full-year sales of $961.48 million for the current fiscal year, with estimates ranging from $4.14 billion to $4.27 billion. For the next year, analysts forecast that the company will report sales of $4.44 billion per share, with estimates ranging from $4.38 billion to $4.55 billion. Zacks’ sales averages are an average based on a survey of analysts that that provide coverage for DENTSPLY SIRONA.

How to Become a New Pot Stock Millionaire

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 EPS for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.01. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. DENTSPLY SIRONA had a negative net margin of 39.39% and a positive return on equity of 8.35%. The business’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.67 earnings per share.

A number of research analysts have recently commented on XRAY shares. Credit Suisse Group cut shares of DENTSPLY SIRONA to a “hold” rating and set a $73.00 price target on the stock. in a report on Friday, January 5th. HC Wainwright cut shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target on the stock. in a report on Thursday, November 30th. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 8th. JPMorgan Chase & Co. upgraded shares of DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 price target on the stock in a report on Wednesday, December 13th. Finally, Deutsche Bank started coverage on shares of DENTSPLY SIRONA in a report on Friday, December 8th. They issued a “buy” rating and a $81.00 price target on the stock. Three analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $67.43.

DENTSPLY SIRONA stock opened at $50.71 on Friday. The company has a quick ratio of 1.45, a current ratio of 2.10 and a debt-to-equity ratio of 0.24. The company has a market cap of $11,530.19, a PE ratio of 19.06, a PEG ratio of 2.21 and a beta of 1.21. DENTSPLY SIRONA has a 1-year low of $50.62 and a 1-year high of $68.98.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend is Wednesday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -5.09%.

In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of the stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the sale, the director now directly owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.99% of the stock is owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in XRAY. NuWave Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $121,000. Focused Wealth Management Inc lifted its position in shares of DENTSPLY SIRONA by 79.2% during the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock valued at $171,000 after buying an additional 1,149 shares during the last quarter. Stock Yards Bank & Trust Co. purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $203,000. Capital One National Association purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $204,000. Finally, Boston Common Asset Management LLC purchased a new stake in shares of DENTSPLY SIRONA during the fourth quarter valued at about $212,000. 96.80% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “DENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $961.48 Million” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/3298966/dentsply-sirona-inc-xray-expected-to-announce-quarterly-sales-of-961-48-million.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cerner  Receives Daily Media Impact Rating of 0.22
Cerner Receives Daily Media Impact Rating of 0.22
Favorable Media Coverage Somewhat Unlikely to Impact Expedia  Share Price
Favorable Media Coverage Somewhat Unlikely to Impact Expedia Share Price
Principal Financial Group  Receiving Somewhat Favorable News Coverage, Accern Reports
Principal Financial Group Receiving Somewhat Favorable News Coverage, Accern Reports
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Willis Towers Watson  Share Price
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Willis Towers Watson Share Price
Ethorse Price Reaches $0.0568
Ethorse Price Reaches $0.0568
Upfiring  Trading Down 7.7% Over Last 7 Days
Upfiring Trading Down 7.7% Over Last 7 Days


© 2006-2018 Ticker Report. Google+.